Table 3.
Association (rs) between lipid levels in serum and cell membranes and clinical characteristics in patients
| S-triglyceride | S-cholesterol | RBC PUFA | RBC LCPUFA | |||||
|---|---|---|---|---|---|---|---|---|
| T1 | T2 | T1 | T2 | T1 | T2 | T1 | T2 | |
| PANSS total | 0.06 | 0.26 | 0.01 | 0.15 | 0.08 | 0.14 | 0.09 | 0.31* |
| PANSS negative | 0.18 | 0.26 | 0.19 | 0.11 | 0.21 | 0.32* | 0.20 | 0.52*** |
| PANSS positive | −0.04 | 0.28* | −0.03 | 0.22 | −0.02 | 0.01 | −0.07 | 0.11 |
| GAF-S | 0.13 | −0.48*** | 0.26 | −0.30* | −0.24 | −0.22 | −0.26 | −0.32* |
| GAF-F | 0.07 | −0.32* | 0.24 | −0.23 | −0.19 | −0.21 | −0.23 | −0.29* |
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001
Spearman’s correlation coefficient is reported
PANSS positive and negative syndrome scale
GAF global assessment of functioning, S symptoms, F functioning)
PANSS Positive positive component; items P1 + P3 + P5 + P6 + G9
PANSS Negative negative component; items N1 + N2 + N3 + N4 + N6 + G7 + G8 + G16
PUFA = omega-3 + omega- 6 polyunsaturated fatty acids in red blood cells (RBC)
LCPUFA = omega-3 + omega-6 PUFA with 20 or more carbon atoms in red blood cells (RBC)